PORTLAND, Maine — Early Sunday morning, hundreds showed up to attend an annual Walk to Defeat ALS in Portland. Amyotrophic lateral sclerosis, also known as Lou Gehrig's disease, is a progressive ...

China’s National Intellectual Property Administration has issued notification to grant patent to PolTREG Chinese patent covers intrathecal administration of PolTREG’s PTG-007 Treg cell therapy to ...

Clene (NASDAQ: CLNN), a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, will be meeting in ...

People with rare genetic variants linked to degenerative brain disorders like Parkinson's disease are at increased risk of ...

The Phase 1 clinical trial is expected to enroll about 60 participants to test how safe and well tolerated multiple doses of ...

A blood test has been shown to accurately identify patients with amyotrophic lateral sclerosis at early stages, which could ...

Synchron today announced the first use of Amazon's Alexa by a patient implanted with its brain-computer interface (BCI).

For CNM-Au8, Clene has more than 700 patient-years of safety data that show no significant safety concerns or safety trends identified. No serious adverse events (SAEs) have been identified as related ...

Martin Hendrickson was diagnosed with Bulbar ALS 2 years ago. One of his dreams was to get behind the wheel on a racetrack, ...

Selection of the development candidate triggered a $3 million milestone payment to Voyager, which the Company expects to receive in the fourth quarter of 2024. Voyager is eligible to receive ...

Neuralink rival Synchron is connecting its brain–computer interface with consumer technologies to allow people with paralysis ...